Recurrent infection with Pseudomonas aeruginosa during eculizumab therapy in an allogeneic hematopoietic stem cell transplant recipient

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplant infectious disease 2016-04, Vol.18 (2), p.312-314
Hauptverfasser:	Webb, B.J., Healy, R., Child, B., Majers, J., Anand, S., Gouw, L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Atypical Hemolytic Uremic Syndrome - drug therapy Atypical Hemolytic Uremic Syndrome - etiology complement eculizumab Fatal Outcome hematopoietic stem cell transplant Hematopoietic Stem Cell Transplantation - adverse effects Hodgkin Disease - therapy Humans Immunocompromised Host Male Pneumonia, Bacterial - microbiology Pseudomonas aeruginosa Pseudomonas Infections - microbiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!